Radiation oncology practice during COVID-19 pandemic in developing countries

Abstract

Radiation therapy (RT) is considered one of the cornerstone modalities of treatment for different cancer types. The preparation and delivery of RT requires a number of staff members from different disciplines within the radiation oncology department. Since the emergence of the corona virus disease 2019 (COVID-19) pandemic, RT, similar to other cancer care modalities, has been adapted to minimize patient and staff exposure without compromising the oncological outcomes. This was reflected in the dramatic practice changes that occurred in the past year to address the lockdown restrictions and fulfill the infection control requirements. RT practices differ across regions based on financial and training levels, and developing countries with limited resources have struggled to maintain radiation treatment services at a level equivalent to that in developed countries while following pandemic control guidelines. The response during the COVID-19 pandemic varied between developing countries according to the infection rate and RT technological capabilities. In this editorial, we review recently published articles addressing radiotherapy practice reports during the COVID-19 pandemic in developing countries.

Impact of the COVID-19 pandemic on Radiation Therapy Practice: A Catalyst for Research

“… 22 , 23 Evidence also suggests that access to remote working is not universally available and is limited in low- and middle-income countries (LMICs) and developing countries. 24 , 25 In many industries, hybrid working or a full time “return to the office” policies have been introduced. Research in this area is largely retrospective and focuses on changes already implemented.…”